Details of the Drug | DrugMAP

General Information of Drug (ID: DM3HL5F)

Drug Name

FB-101

Synonyms

NULL

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C19H23F2N3O2
Canonical SMILES: C1CCCN(CC1)C2=C(C(=C3CC(=CN(C3=C2F)C4CC4)C(=O)O)N)F
InChI: InChI=1S/C19H23F2N3O2/c20-14-16(22)13-9-11(19(25)26)10-24(12-5-6-12)17(13)15(21)18(14)23-7-3-1-2-4-8-23/h10,12H,1-9,22H2,(H,25,26)
InChIKey: XIADACXCBGCKCI-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 101693174
TTD ID: DI6EL3

References

1	ClinicalTrials.gov (NCT04165837) A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects. U.S.National Institutes of Health.